2011 Chief Legal Officer Leadership Forum: Spotlight on Pharmaceuticals & Biotechnology
(Philadelphia)
Wednesday, December 14, 2011
Philadelphia, PA
Perspectives By:
Joseph Bonaccorsi
Senior Vice President General Counsel and Secretary
Akorn, Inc.
Michael Brew
Attorney / Partner
Carter, DeLuca, Farrell, Schmidt
Eve Costopoulos
Vice President, Chief Ethics & Compliance Officer
Eisai, Inc
Alina Denis Jarjour
Former General Counsel, Secretary & Chief Compliance Officer
EKR Therapeutics, Inc.
Bill Devaul
Associate General Counsel, Intellectual Property and Litigation
Cubist Pharmaceuticals Inc.
Gretchen Fritz
Senior Corporate Counsel
Daiichi Sankyo
Andrew Goodman
Executive Director of Litigation Services
Quislex
Reza Green, Ph.D., J.D.
Chief Intellectual Property Counsel
Novo Nordisk Inc.
Peg Hall
Partner
SNR Denton
Jerome Jabbour
Senior Vice President, Head of Global Legal Affairs and U.S. General Counsel
Wockhardt
Gil Labrucherie
SVP & General Counsel
Nektar Therapeutics
Chan Lee
VP and Assistant General Counsel, Chief Counsel Pfizer Oncology
Pfizer Inc.
Lara Levitan
Div. V.P. & Assoc. Gen. Counsel
Abbott Laboratories
Richard Murphy
Vice President, Intellectual Property
Sanofi Pasteur
Maria Pasquale
Chief Counsel & Senior Vice President, Legal
Celgene Corporation
Seth L. Rodner
SVP, General Counsel & Corporate Secretary
Medicis Pharmaceutical Corporation
Charles Ryan
Senior Vice President, Chief Intellectual Property Counsel
Forest Laboratories
Jeff Seymour
Principal, Analytic & Forensic Technology
Deloitte
Stephen Stewart
Chief Technology Officer
Nuix
Caroline West
Senior Vice President, Chief Compliance and Risk Officer
Shire Pharmaceuticals
Steven Zalesin
Partner
Patterson Belknap Webb & Tyler
Summary:
The success of the pharmaceutical & biotech industries in large part depends on the ability of its legal executives to implement the correct market protection strategies. The protection of patents and IP, including the anticipation of vulnerable patents and litigation, are an integral part of life cycle management, market growth and brand optimization.
These are amongst the topics that will be addressed on December 14th, when Argyle Executive Forum will host its Chief Legal Officer Leadership Forum: Spotlight on Pharmaceuticals & Biotechnology, taking place in Philadelphia.
Argyle meetings are by invitation only. If you did not receive an invitation but would like to inquire about attendance, please click here.
*Press policies for member meetings are set at the individual session level. Some sessions may be on the record, while others are off. Please consult the meeting agenda, which will indicate which sessions are off the record. To inquire about media presence, please click here.
Date: Wednesday, December 14, 2011
Time: 8:00am – 4:40pm
Location: Philadelphia, PA
*Event location will be disclosed to attendees upon completion of the registration process.
- Event Advisors
- Meeting Overview
- Agenda
- Speaking Faculty
- Partners
- Participation Requirements
- Member Substitution Policy
- Travel and Other Information
- Support the Meeting
Advance registration is required for all member meetings. Registration is not available onsite.
To download the program from this member meeting please fill out the form below: